Evidence map›Paper›PMID 31090666›Full record

ArticlePancreas

FAM111B Mutation Is Associated With Pancreatic Cancer Predisposition.

Sandra Mercier, Sébastien Küry, Sophie Nahon, Emmanuelle Salort-Campana, Sébastien Barbarot, Stéphane Bézieau

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Pancreas. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Functions and evolution of FAM111 serine proteases.Frontiers in molecular biosciences · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Sandra MercierService de Génétique Médicale CHU de Nantes Nantes, France L'institut du Thorax, INSERM, CNRS, UNIV Nantes Nantes, France sandra.mercier@chu-nantes.fr Service Hématologie-Oncologie Centre Hospitalier du Pays d'Aix Aix-en-Provence, France Service de Neurologie Centre de Référence des Maladies Neuromusculaires PACA-Réunion-Rhône Alpes FILNEMUS CHU Hôpital de la Timone Marseille, France Clinique Dermatologique CHU de Nantes Nantes, France Service de Génétique Médicale CHU de Nantes Nantes, France L'institut du Thorax, INSERM, CNRS UNIV Nantes Nantes, France.
Sébastien Küry
Sophie Nahon
Emmanuelle Salort-Campana
Sébastien Barbarot
Stéphane Bézieau
Centre d'Investigation Clinique de Nantes · FRInstitut du Thorax · FRGénétique Médicale & Génomique Fonctionelle · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pancreatic NeoplasmsCell Cycle ProteinsHumansMutationCell Cycle ProteinsFAM111B protein, human

Identifiers

PMID31090666
OpenAlexW2945457913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.